The impact of hepatitis C virus NS5A protein mutations on interferon alfa (IFN-␣) signaling pathway, cell proliferation, and viability is an important issue that is still under debate. We have therefore combined transient and stable expression in a human hepatocytic cell line (Huh7) of 3 full-length NS5A sequences, isolated from patients with or without response to IFN-␣ therapy. Expression of all 3 NS5A-reduced IFN-␣ global antiviral activity on both vesicular stomatitis virus (VSV) and encephalomyocarditis virus (EMCV) replication. We did not show, however, an effect of these 3 NS5A proteins on double-stranded RNA-dependent kinase (PKR) expression and activity as well as colocalization and coimmunoprecipitation between NS5A and PKR. We also failed to show an effect of the 3 NS5A mutants tested on cell proliferation and viability. Overall Hepatitis C virus (HCV) is a positive-stranded RNA virus classified as hepacivirus in the Flaviridae family, which exhibits marked viral heterogeneity. 1 The polyprotein precursor is co-and post-translationally processed by both cellular and viral proteases to yield mature, structural and nonstructural proteins. 2-4 HCV is a highly prevalent pathogen and at least 300 million individuals are chronically infected worldwide. 5 The establishment of chronic infection is a major feature of HCV infection, because around 70% to 80% of acutely infected subjects will become chronic carriers, with a high subsequent risk of progression to cirrhosis and hepatocarcinoma. 6 Therapy using interferon alfa (IFN-␣) alone, or in combination with ribavirin, has been shown to be effective in chronic hepatitis C infection, but only 8% to 12% and 30% to 40% of treated patients, respectively, depending on HCV type, viral load, and quasispecies complexity, show a sustained virologic response. [7][8][9] In this context, appraisal of the mechanisms of viral resistance to IFN-␣ therapy is crucial.Several studies have suggested a direct interplay between HCV and IFN-␣-induced cellular signaling. 10,11 Expression of HCV polyprotein in osteosarcoma cells inhibits Jak1-STAT signaling. 12 HCV nonstructural protein NS5A of HCV type 1 has been particularly investigated. In Japanese HCV-1b isolates, an inverse correlation was indeed observed between the number of mutations in a region of NS5A, referred to as the interferon-sensitivity determining region (ISDR; position 2209-2248), and the response to IFN-␣ treatment. 13,14 Such a strict correlation between ISDR mutations and treatment efficacy has not, however, been shown in most studies performed in Europe and the United States. [15][16][17][18][19][20][21] Furthermore, NS5A sequence variability in domains located outside the ISDR, and in particular in the C-terminal part of the protein, is probably also implicated in therapeutic efficacy. 22 Expression of fulllength NS5A-1b but not of ISDR-deleted mutant, renders osteosarcoma 11 and murin fibroblastic cell lines 23 partially resistant to the antiviral effect of IFN-␣ against encephalomyocarditis virus (EMCV) an...